TrademarkDir
ORAVANCE
LIVE

Serial Number

88338791

Owner

QPEX BIOPHARMA, INC.

Attorney

Gregory B. Phillips

First Use Date

Aug 18, 2022

Filing Date

Mar 13, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ORAVANCE Trademark

Serial Number: 88338791 • Registration: 7115573

ORAVANCE is a trademark filed by QPEX BIOPHARMA, INC. on March 13, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

QPEX BIOPHARMA, INC. (3 trademarks)

San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

March 13, 2019

Registration Date

July 18, 2023

First Use Anywhere

August 18, 2022

First Use in Commerce

August 18, 2022

Published for Opposition

September 17, 2019

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 18, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 18, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 16, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 15, 2023 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 13, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 12, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 12, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 10, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Mar 10, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 12, 2022 GNRN
NON-FINAL ACTION E-MAILED
Dec 12, 2022 GNRT
SU - NON-FINAL ACTION - WRITTEN
Dec 12, 2022 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Nov 14, 2022 SUPC
USE AMENDMENT FILED
Nov 11, 2022 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 11, 2022 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 10, 2022 EXRA
SOU EXTENSION 5 GRANTED
May 9, 2022 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 9, 2022 AITU
SOU EXTENSION 5 FILED
May 2, 2022 EXT5
SOU TEAS EXTENSION RECEIVED
May 2, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 14, 2021 EXRA
SOU EXTENSION 4 GRANTED
Oct 12, 2021 EX4G
SOU EXTENSION 4 FILED
Oct 12, 2021 EXT4
SOU TEAS EXTENSION RECEIVED
Oct 12, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 5, 2021 EXRA
SOU EXTENSION 3 GRANTED
May 3, 2021 EX3G
SOU EXTENSION 3 FILED
May 3, 2021 EXT3
SOU TEAS EXTENSION RECEIVED
May 3, 2021 EEXT
ASSIGNED TO EXAMINER
Dec 14, 2020 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 6, 2020 EXRA
SOU EXTENSION 2 GRANTED
Nov 4, 2020 EX2G
SOU EXTENSION 2 FILED
Nov 4, 2020 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 4, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 6, 2020 EXRA
SOU EXTENSION 1 GRANTED
May 4, 2020 EX1G
SOU EXTENSION 1 FILED
May 4, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
May 4, 2020 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 12, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 17, 2019 NPUB
PUBLISHED FOR OPPOSITION
Sep 17, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 28, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 13, 2019 CNSA
ASSIGNED TO EXAMINER
Jul 24, 2019 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 11, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 10, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 10, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 28, 2019 GNRN
NON-FINAL ACTION E-MAILED
May 28, 2019 GNRT
NON-FINAL ACTION WRITTEN
May 28, 2019 CNRT
ASSIGNED TO EXAMINER
May 22, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 1, 2019 NWOS
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Mar 30, 2019 AMPX
ASSIGNED TO LIE
Mar 28, 2019 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Mar 22, 2019 PARI
NEW APPLICATION ENTERED
Mar 16, 2019 NWAP

Related Trademarks

More from this Owner

OMNIVANCE

OMNIVANCE

OMNIVANCE

OMNIVANCE

OMNIVANCE

OMNIVANCE

QPEX BIOPHARMA

QPEX BIOPHARMA

QPEX BIOPHARMA

QPEX BIOPHARMA

QPEX BIOPHARMA

QPEX BIOPHARMA